New Blood Test for Colorectal Cancer Screening

SOURCE www.foxnews.com
FDA approves new blood test for colorectal cancer screening, offering a simpler and less invasive option compared to colonoscopy. The test has an 83% sensitivity for detecting colorectal cancer.

Key Points

  • FDA approves Shield, a blood test for colorectal cancer screening
  • Test has 83% sensitivity for detecting colorectal cancer
  • Offered as a primary screening option for average-risk individuals aged 45 and older

Pros

  • Simpler and less invasive than colonoscopy
  • Can be done during a routine doctor's appointment
  • Designed for average-risk individuals aged 45 and older

Cons

  • Lower sensitivity compared to some stool tests
  • Not as effective in preventing colorectal cancer by detecting and removing precursor lesions